New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies

This Medical News article discusses a clinical trial for an HIV vaccine that uses germline targeting, a novel technique to induce rare immune cell precursors of broadly neutralizing antibodies.